본문 바로가기
카테고리 없음

[루미나] 20211116_10-k 분석(재무제표)

by 인생오십년 2021. 11. 16.

먼저 뉴스로도 뜨고 다양한 매체에서 다뤄서 재무구조가 매우 좋아졌다는 사실은 아실거라고 생각됩니다. 그래도 한번 어떤식으로 좋아졌는지 공식자료를 살펴보겠습니다. 

 

 

1. Condensed Consolidated Balance Sheets
(In thousands)
                       
  September 30, 2021   December 31, 2020
  (Unaudited)    
ASSETS      
Current assets:      
Cash and cash equivalents $ 129,323      $ 208,944   
Restricted cash 725      775   
Marketable securities 415,544      276,710   
Accounts receivable 1,033      5,971   
Inventories, net 7,871      3,613   
Prepaid expenses and other current assets 23,883      4,797   
Total current assets 578,379      500,810   
Property and equipment, net 11,128      7,689   
Operating lease right-of-use assets 10,165      —   
Intangible assets, net 2,488      —   
Goodwill 3,110      701   
Other non-current assets 2,536      1,151   
Total assets $ 607,806      $ 510,351   
       
LIABILITIES AND STOCKHOLDERS’ EQUITY      
Current liabilities:      
Accounts payable $ 9,682      $ 6,039   
Accrued and other current liabilities 18,551      10,452   
Operating lease liabilities 4,927      —   
Debt, current 66      99   
Total current liabilities 33,226      16,590   
Warrant liabilities 27,753      343,400   
Debt, non-current 177      302   
Operating lease liabilities, non-current 6,639      —   
Other non-current liabilities 911      1,318   
Total liabilities 68,706      361,610   
Commitments and contingencies (Note 13)      
Stockholders’ equity:      
Class A common stock 26      22   
Class B common stock 10      11   
Additional paid-in capital 1,287,558      733,175   
Accumulated other comprehensive income 100      34   
Accumulated deficit (748,594)     (584,501)  
Total stockholders’ equity 539,100      148,741   
Total liabilities and stockholders’ equity $ 607,806      $ 510,351   
우선 인상깊은 것은 총 부채가 대폭 감소했다는 사실입니다. 기존 361,610천달러에서 68,706천달러로 대폭 감소했습니다. 
이에 따라 부채비율도 11%로 매우 낮아졌습니다. 

 


2. Condensed Consolidated Statements of Operations and Comprehensive Loss
(Unaudited, in thousands, except share and per share data)
                                               
  Three Months Ended September 30,   Nine Months Ended September 30,
  2021   2020   2021   2020
Revenue $7,978    $4,223    $19,600    $11,519 
Cost of sales 10,762      6,924      26,254      18,209   
Gross loss (2,784)     (2,701)     (6,654)     (6,690)  
Operating expenses:              
Research and development 25,890      10,152      59,813      28,268   
Sales and marketing 5,868      2,332      12,010      5,407   
General and administrative 35,603      6,611      65,113      16,116   
Total operating expenses 67,361      19,095      136,936      49,791   
Loss from operations (70,145)     (21,796)     (143,590)     (56,481)  
Other income (expense), net:              
Change in fair value of warrant liabilities 17,072      (7,988)     (22,649)     (12,562)  
Loss on extinguishment of debt —      —      —      (866)  
Interest expense and other (374)     (1,076)     (860)     (2,097)  
Interest income and other 843      (351)     1,744      (221)  
Total other income (expense), net 17,541      (9,415)     (21,765)     (15,746)  
Loss before benefit from income taxes (52,604)     (31,211)     (165,355)     (72,227)  
Benefit from income taxes (1,264)     —      (1,262)     —   
Net loss $ (51,340)     $ (31,211)     $ (164,093)     $ (72,227)  
Net loss attributable to common stockholders $ (51,340)     $ (37,458)     $ (164,093)     $ (78,474)  
Net loss per share attributable to common stockholders:              
Basic and diluted $ (0.15)     $ (0.29)     $ (0.48)     $ (0.61)  
Shares used in computing net loss per share attributable to common stockholders:              
Basic and diluted 352,122,485      130,601,660      341,858,435      129,643,774   
Comprehensive Loss:              
Net loss $ (51,340)     $ (31,211)     $ (164,093)     $ (72,227)  
Net unrealized gains (losses) on available-for-sale debt securities 93      (28)     66      (19)  
Comprehensive loss $ (51,247)     $ (31,239)     $ (164,027)     $ (72,246)  
See accompanying notes to the unaudited condensed consolidated financial statements.

사람들이 주목해서 본 쪽은 오히려 매출쪽입니다. 작년 동기 대비 88% 상승한 7,978천달러 입니다. 아직 시가총액과 비교하면 보잘것 없는 매출이지만 상승폭이 높고, 아직 본격적으로 라이다를 대량생산하지 않았음에도 이 정도 수치가 나온다는 점에서 놀랄만 합니다.  

 

하지만 그래도 순손실이 늘어났고, 적자가 개선되지 않았다는 점에서 주가 상승 발목을 잡고 있습니다. 만약 적자까지 개선했다면 30%이상 올랐을 텐데 말이죠. 연구비용이 두배이상 증가했고 판관비도 큰폭으로 증가했습니다. 아무래도 대규모 영입(과, 큰 회사(엔비디아)들과 손잡는 과정에서 비용이 많이 들어간 것으로 추측됩니다. 

참고: https://canarygreen.tistory.com/351?category=945636 

 

[루미나] 2명의 재무 및 기술 전문가를 이사회에 영입

출처: https://www.businesswire.com/news/home/20210609005823/en/Luminar-Recruits-Two-Finance-and-Technology-Leaders-to-Board-of-Directors Today, Luminar Technologies, Inc. (Nasdaq: LAZR), the global..

canarygreen.tistory.com

그래도 확실히 재무전문가가 영입되니 회사 재무상태가 눈에 띄게 좋아지는 것을 확인 할 수 있었습니다. 

 

3. Condensed Consolidated Statements of Cash Flows

 

(Unaudited, in thousands)
                       
  Nine Months Ended September 30,
  2021   2020
Cash flows from operating activities:      
Net loss $ (164,093)     $ (72,227)  
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 2,240      1,929   
Noncash lease expense related to operating lease right-of-use assets 2,682      —   
Change in fair value of warrants 22,649      12,562   
 Share-based compensation—vendor payments 2,744      —   
Impairment of inventories 1,601      4,393   
Loss on extinguishment of debt —      866   
Share-based compensation 49,887      4,710   
Warranty related to sensors 1,239      —   
Deferred taxes (1,264)     —   
Other 883      389   
Changes in operating assets and liabilities:      
Accounts receivable 5,748      723   
Inventories (6,658)     (3,206)  
Prepaid expenses and other current assets (16,971)     (3,571)  
Other non-current assets (88)     544   
Accounts payable 3,330      2,462   
Accrued and other current liabilities 5,910      2,885   
Other non-current liabilities (4,095)     (190)  
Net cash used in operating activities (94,256)     (47,731)  
Cash flows from investing activities:      
Cash received from acquisition of Optogration, Inc. 358      —   
Purchases of marketable securities (530,179)     (123,403)  
Proceeds from maturities of marketable securities 306,907      8,465   
Proceeds from sales of marketable securities 83,493      4,448   
Purchases of property and equipment (4,155)     (1,963)  
Net cash used in investing activities (143,576)     (112,453)  
Cash flows from financing activities:      
Proceeds from issuance of Series X convertible preferred stock —      170,000   
Issuance cost paid for Series X convertible preferred stock —      (5,662)  
Proceeds from the issuance of debt —      31,910   
Repayment of debt (159)     (11,206)  
Proceeds from exercise of warrants 153,927      —   
Proceeds from exercise of stock options 4,738      —   
Other financing activities (345)     (1,238)  
Net cash provided by financing activities 158,161      183,804   
Net increase (decrease) in cash, cash equivalents and restricted cash (79,671)     23,620   
Beginning cash, cash equivalents and restricted cash 209,719      27,305   
Ending cash, cash equivalents and restricted cash $ 130,048      $ 50,925   
Supplemental disclosures of cash flow information:      
Cash paid for interest $ 53      $ 2,013   
Supplemental disclosures of noncash investing and financing activities:      
Issuance of Class A common stock upon exercise of warrants $ 338,293      $ —   
Operating lease right-of-use assets obtained in exchange for lease obligations upon adoption of ASC 842 10,849      —   
Operating lease right-of-use assets obtained in exchange for lease obligations 2,876      —   
Assets acquired under finance leases (capital lease prior to adoption of ASC 842) —      43   
Purchases of property and equipment recorded in accounts payable and accrued liabilities 543      313   
Merger related expense recorded in accounts payable and accrued liabilities —      3,669   
Issuance cost for Series X preferred stock recorded in accounts payable —      227   
숫자가 큰 것들만 살펴보면 유가증권을 대량 구매한 것이 있습니다. (Purchases of marketable securities, (530,179))

Beginning cash, cash equivalents and restricted cash (현금성 자산 및 보증금)도 큰 폭으로 늘었습니다. 대량생산 시설을 위한 대규모 채권발행이나 다른 이슈가 있을 것으로 예상됩니다. 

 

그래도 연초 약속했던 것처럼(비지니스 업데이트에서 CEO 발언) 재무상태도 개선되고, 실적도 어느정도 나와줘서 다행입니다. 머스크처럼 쇼맨쉽은 없지만(없어도 됨) 착실한 CEO라 믿고 갈 수 있겠습니다. 

 

 

 

댓글